Mediastinoscopy — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Mediastinoscopy is a minimally invasive surgical diagnostic procedure that provides direct visualisation and biopsy access to the mediastinum — the anatomical compartment in the central chest between the two lungs, containing the heart, great vessels, trachea, oesophagus, thymus gland, and lymph node chains. The mediastinum harbours lymph nodes that drain the lungs and are critical staging sites in non-small cell lung cancer (NSCLC), where the presence of mediastinal lymph node metastases (N2 or N3 disease) fundamentally changes operability and treatment decisions. Cervical mediastinoscopy — the standard technique — accesses the superior and anterior mediastinum through a small transverse incision in the suprasternal notch (just above the sternum), advancing a rigid illuminated mediastinoscope along the anterior surface of the trachea into the superior mediastinum to biopsy lymph node stations 2R, 2L, 4R, 4L, and 7. Anterior mediastinotomy (Chamberlain procedure) uses a small left parasternal incision to access the aortopulmonary window (station 5) and anterior mediastinum. Video-assisted mediastinoscopy (VAMS) — using a two-channel scope allowing both visualisation and simultaneous biopsy with improved ergonomics — has replaced conventional single-channel mediastinoscopy at many centres. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is increasingly performed before mediastinoscopy as a less invasive initial staging technique.

Mediastinoscopy is indicated primarily for the staging and diagnosis of conditions involving the mediastinal lymph nodes and anterior mediastinal masses. Lung cancer staging: mediastinoscopy remains the gold-standard confirmatory staging procedure when CT-PET imaging suggests mediastinal lymph node involvement in potentially resectable NSCLC. A positive CT-PET scan at mediastinal nodes requires histological confirmation before denying surgery; false-positive rates on PET scan are 10–20%. Mediastinoscopy is also performed when EBUS-TBNA fails to obtain diagnostic tissue despite suspicious imaging. Sarcoidosis diagnosis: bilateral hilar lymphadenopathy on CT with a compatible clinical picture is frequently confirmed by mediastinoscopy, providing tissue for granuloma histology and culture. Lymphoma staging and typing: anterior mediastinal masses (typical of Hodgkin's lymphoma, thymic tumours, or germ cell tumours) may require more tissue than core needle biopsy provides; mediastinoscopy or anterior mediastinotomy provides adequate tissue for complete lymphoma subtyping essential for treatment selection. Thymoma staging and diagnosis in selected cases. Tuberculous mediastinal lymphadenitis — where EBUS-TBNA may be non-diagnostic despite visible nodes — may require mediastinoscopy for culture and sensitivity in drug-resistant TB. Repeat staging mediastinoscopy (re-mediastinoscopy) — technically more demanding due to adhesions — is performed in select patients with NSCLC after neoadjuvant chemotherapy to confirm mediastinal lymph node downstaging before proceeding to surgical resection.

Cervical mediastinoscopy is performed under general anaesthesia with endotracheal intubation. The patient is positioned supine with the neck extended and a roll under the shoulders. A transverse skin incision approximately 3 cm long is made in the suprasternal notch. Dissection proceeds through the platysma and pretracheal fascia to reach the anterior surface of the trachea; the pretracheal plane is developed bluntly by finger dissection, creating a path into the superior mediastinum anterior to the trachea. The mediastinoscope is advanced under direct vision along the pretracheal plane. Systematic exploration of the mediastinum identifies lymph node stations 2R and 2L (upper paratracheal), 4R and 4L (lower paratracheal), and station 7 (subcarinal). Before biopsy of any structure, a needle aspiration is performed to confirm the absence of vascular contents — the great vessels (aorta, pulmonary artery, superior vena cava) are adjacent to the lymph node stations and inadvertent biopsy of a vessel would cause fatal haemorrhage. Biopsies are taken using cupped forceps through the mediastinoscope; multiple core samples are sent for histology, microbiology (TB culture), and flow cytometry (for lymphoma). Haemostasis is achieved with diathermy or packing. The incision is closed in layers with a small subcuticular suture and Steri-Strip dressings; no drain is required in uncomplicated cases. Operative time is 30–60 minutes. A chest radiograph is obtained in recovery to exclude pneumothorax.

Cervical mediastinoscopy has an overall diagnostic sensitivity of 89–95% and specificity approaching 100% for detecting mediastinal lymph node metastases in lung cancer, with a negative predictive value of 91–95% — meaning that a negative mediastinoscopy reliably confirms N2-negative disease and supports proceeding to surgical resection. This accuracy exceeds that of CT-PET scan alone (sensitivity 62–81%, specificity 91–96%) and makes it the definitive staging investigation when imaging is equivocal or positive. In sarcoidosis, mediastinoscopy achieves histological diagnosis in over 90% of cases with bilateral hilar lymphadenopathy, avoiding more invasive open surgical biopsy. For anterior mediastinal masses, a definitive tissue diagnosis guides treatment planning — distinguishing lymphoma (treated with chemotherapy or radiation) from thymoma (treated surgically) from germ cell tumour — critical differences that determine whether surgery is the appropriate primary treatment. The procedure's minimal invasiveness — a 3 cm neck incision, day-case or overnight admission, and return to normal activity within 5–7 days — makes it well-tolerated in patients who may otherwise be undergoing evaluation before major thoracic surgery or chemotherapy. Mediastinoscopy prevents futile thoracotomy in patients with mediastinal N2 disease who would not benefit from primary surgical resection.

Mediastinoscopy is a low-risk procedure at experienced thoracic surgery centres, with a major complication rate of approximately 1–2%. Major haemorrhage — from inadvertent biopsy or laceration of the great vessels (aorta, azygos vein, innominate artery, or superior vena cava) — is the most feared complication, occurring in approximately 0.5–1% of cases. Because the mediastinal vessels are immediately adjacent to the lymph nodes, careful pre-biopsy aspiration with a needle to exclude vascular structures is mandatory. Haemorrhage may require emergency sternotomy for repair; most modern series report no mortality from vascular injury at experienced centres. Left recurrent laryngeal nerve injury — the nerve courses along the left side of the trachea and aortic arch — occurs in less than 1% and causes hoarseness; most cases recover within 3–6 months. Tracheal laceration is extremely rare. Wound infection of the suprasternal incision occurs in less than 1%. Pneumothorax from inadvertent pleural entry is uncommon (less than 1%) and detected on the post-procedure chest radiograph; observation is adequate for small pneumothoraces. Mediastinal haematoma without active bleeding may occur, presenting as neck swelling or dysphagia, and usually resolves conservatively. The superior mediastinal approach via the suprasternal incision does not access the aortopulmonary window (station 5/6 lymph nodes); anterior mediastinotomy is required for these nodes, representing a technical limitation of standard cervical mediastinoscopy.

Most patients are observed for 2–4 hours in the recovery room after mediastinoscopy. Uncomplicated cases are discharged the same day or after one overnight stay. A chest radiograph is reviewed before discharge to exclude pneumothorax. The suprasternal incision is small (3 cm) and closed with subcuticular sutures; Steri-Strip dressings are applied and the wound is kept dry for 5–7 days. Wound sutures dissolve or are removed at 7–10 days; the small scar typically heals to a thin, barely visible line within 6–12 weeks. Activity restrictions: light activity and return to desk work within 3–5 days; avoidance of heavy lifting or strenuous exertion for 1–2 weeks. Mild post-operative sore throat from endotracheal intubation — not from the procedure itself — resolves within 24–48 hours. The biopsy histology results are typically available within 48–72 hours for routine pathology, or up to 6–8 weeks for mycobacterial culture results. Results are discussed at a multidisciplinary team (MDT) meeting in the context of full staging investigations — particularly for lung cancer — to determine the appropriate treatment strategy. In lung cancer staging, if mediastinoscopy confirms N2 node positivity, the patient is counselled regarding neoadjuvant chemotherapy before potential surgical reassessment or radical radiotherapy as definitive treatment.